Pricing Log in Create free account
Saturday 17 October 2026 Export ILMN’s income statement to Excel — free account

Illumina, Inc.

ILMN Healthcare Diagnostics & Research

Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024. In the quarter to June 2026, revenue grew 9.44%, EPS fell 8.05%, free cash flow fell 18.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

262.03 5.90 −2.20%
Market cap
$40.5B
P/E
48.4×
Fwd P/E
34.7×
Dividend yield
—
F-score
8/9
Altman Z
4.39
Beneish M
−2.51
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Illumina, Inc. (ILMN) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Illumina, Inc. (ILMN) trades at a EV/EBITDA of 35.0×. Over the past ten years it has ranged from 0.0× (June 2025) to 392× (January 2022); the current reading is higher than 54% of that period. That is above the Diagnostics & Research industry median of 24.3× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 19.2× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 352× 461.53%
FY2020 62.7× 69.13%
FY2019 37.1× (1.13%)
FY2018 37.5× (3.75%)
FY2017 39.0× 61.86%
FY2016 24.1× (29.96%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 23.7× 35.05%
Mar 2026 17.5× (8.62%)
Dec 2025 19.2× 37.32%
Sep 2025 14.0× 38.96%
42 more quarters

Against its own ten years

Low 0.0× High 392×
Ten-year median 33.5×
Current reading's percentile 54

EV/EBITDA against peers

Company EV/EBITDA
NTRA Natera, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 14.1×
LH Labcorp Holdings Inc. compare 14.5×
IQV IQVIA Holdings Inc. compare 17.1×
A Agilent Technologies, Inc. compare 26.5×
MTD Mettler-Toledo International, Inc. compare 26.6×
IDXX IDEXX Laboratories, Inc. compare 27.6×
ILMN Illumina, Inc. 35.0×
WAT Waters Corporation compare 50.1×
Diagnostics & Research industry median 24.3×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ILMN